These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 19836235)

  • 1. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
    Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
    J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
    Li ZL; Li QS; Zhang HJ; Hu Y; Zhu DD; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4413-20. PubMed ID: 21752655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Li HQ; Luo Y; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
    Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
    Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
    Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
    Zhou Y; Du QR; Sun J; Li JR; Fang F; Li DD; Qian Y; Gong HB; Zhao J; Zhu HL
    ChemMedChem; 2013 Mar; 8(3):433-41. PubMed ID: 23401291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.
    Singh S; Soni LK; Gupta MK; Prabhakar YS; Kaskhedikar SG
    Eur J Med Chem; 2008 May; 43(5):1071-80. PubMed ID: 17707951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli beta-ketoacyl-ACP-synthase III (FabH).
    Alhamadsheh MM; Waters NC; Huddler DP; Kreishman-Deitrick M; Florova G; Reynolds KA
    Bioorg Med Chem Lett; 2007 Feb; 17(4):879-83. PubMed ID: 17189694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors.
    Zhou Y; Yang YS; Song XD; Lu L; Zhu HL
    Chem Pharm Bull (Tokyo); 2017; 65(2):178-185. PubMed ID: 28154310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Ashek A; Cho SJ
    Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
    Li Y; Luo Y; Hu Y; Zhu DD; Zhang S; Liu ZJ; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 Jul; 20(14):4316-22. PubMed ID: 22710102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics.
    Cheng K; Zheng QZ; Qian Y; Shi L; Zhao J; Zhu HL
    Bioorg Med Chem; 2009 Dec; 17(23):7861-71. PubMed ID: 19884012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
    Cheng K; Xue JY; Zhu HL
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4235-8. PubMed ID: 23731945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combine approach of chemical synthesis, biological evaluation and structural dynamics studies revealed thiazole substituted arylamine derivatives as potent FabH enzyme inhibitors.
    Ahmad H; Ahmad F; Parveen S; Ahmad S; Azam SS; Hassan A
    Bioorg Chem; 2020 Dec; 105():104426. PubMed ID: 33161255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel FabH inhibitors: an updated article literature review (July 2012 to June 2013).
    Song H; Ao GZ; Li HQ
    Expert Opin Ther Pat; 2014 Jan; 24(1):19-27. PubMed ID: 24083428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
    Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
    Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
    Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
    Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.